Canadian Psychedelics Company Reduces Manufacturing Time Of MDMA By Two Thirds
Nirvana Life Sciences Inc. (CSE: NIRV) announced that it has engineered a method that reduces the manufacturing time of MDMA by two thirds.
Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries
Psychedelics R&D company Mindset Pharma (OTCQB: MSSTF) has filed no less than 16 national applications, including countries within the main South East Asian markets, for one of its key families of next-generation psychedelic compounds.
Psychedelic Mushrooms Are Going Global: Supply Deal With UK-Based Wellness Company Moves Forward
Expert functional and magic mushrooms grower Optimi Health Corp. (OTCQX: OPTHF) has signed an agreement with Avida Global, a privately-held UK-based producer of white label products including nutraceuticals and medicinal cannabis oils.
Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies
PharmaTher Holdings (OTCQB: PHRRF), the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch, KETARX, in minipigs.
Psychedelic Stock Gainers And Losers From September 7, 2022
GAINERS:
Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.66% at $1.12
Element Apothec Partners With CBD Of Denver To Reach Europe
Element Apothec, a beauty and wellness company, entered into an official partnership with CBD of Denver, Inc. (OTCPK:CBDD), a cannabis parent company and owner of multi-brand cannabis e-commerce and marketing company mellow.
MariMed Appoints Jon Levine As President
MariMed, Inc. (CSE:MRMD), (OTCQX: MRMD) appointed Jon Levine as president.
E-Cigarette Maker To Pay Over $430M To Settle Multi-State Vaping Inquiry, Cannabis Investors Need To Pay Attention
E-cigarette producer Juul Labs agreed to pay $438.5 million to 34 states and territories to sort out a two-year bipartisan investigation into its marketing and sales practices.